CAH vs HSIC
Cardinal Health (CAH) and Henry Schein (HSIC) compared side by side. Cardinal Health (CAH) is larger, with a market cap of $57.8B versus $9.5B for Henry Schein, about 6.1 times the size. On trailing earnings, HSIC is cheaper at 24.8x versus 34.5x for CAH.
Head to head
| Metric | CAH | HSIC |
|---|---|---|
| Market cap | $57.8B | $9.5B |
| P/E (TTM) | 34.5x | 24.8x |
| Forward P/E | 17.8x | 14.2x |
| Revenue (TTM) | $254.2B | $13.6B |
| Revenue growth | 5.8% | 6.7% |
| Gross margin | 3.8% | 31.3% |
| Operating margin | 1.3% | 5.8% |
| Free cash flow | $4.5B | $513.0M |
| Dividend yield | 0.83% | None |
| 1-year return | +58.3% | +33.6% |
| 5-year return (annual) | +41.0% | +1.2% |
| Max drawdown | -62% | -78% |
| FI Handbook grade | C | C+ |
Highlighted: the stronger figure on metrics where higher or lower is clearly better.
Growth of $10,000 (5 years, price only)
CAH vs HSIC FAQ
Which is bigger, CAH or HSIC?
Cardinal Health (CAH) is larger, with a market cap of $57.8B versus $9.5B for Henry Schein, about 6.1 times the size.
Is CAH or HSIC cheaper?
On trailing earnings, HSIC is cheaper at 24.8x versus 34.5x for CAH. A lower P/E can reflect slower expected growth, so compare growth and margins too.
Which stock performed better over the past year, CAH or HSIC?
CAH returned +58.3% over the past year including dividends, versus +33.6% for HSIC, through October 23, 2026.
Which pays a higher dividend, CAH or HSIC?
CAH yields 0.83%; HSIC does not pay a dividend.
Full pages: Cardinal Health · Henry Schein